event,time
Here is the table of events and timestamps:,
15 years old ,0.0
female ,0.0
acute myelogenous leukemia (AML) ,0.0
received standard induction treatment ,0.0
pancytopenia ,-168.0
developed tachycardia ,-168.0
developed hypotension ,-168.0
developed lactic acidosis ,-168.0
admitted to the pediatric intensive care unit ,-168.0
transthoracic echocardiography ,-168.0
severely impaired left ventricular ejection fraction ,-168.0
sinus tachycardia with incomplete right bundle branch block ,-168.0
N-terminal prohormone of brain natriuretic peptide (NT-proBNP) ,-168.0
high-sensitive troponin T ,-168.0
fluid therapy ,-168.0
noradrenaline ,-168.0
dobutamine ,-168.0
milrinone ,-168.0
deep sedation ,-168.0
mechanical ventilation ,-168.0
lactate acidosis worsened ,-168.0
hypotonic ,-168.0
heart rate of 160/min ,-168.0
va-ECMO was initiated ,-168.0
cannulation of the left femoral artery and vein ,-168.0
13 Fr/15 cm arterial and 21 Fr/55 cm venous HLS Cannula ,-168.0
Seldinger technique under sonographic guidance ,-168.0
9 Fr sheath ,-168.0
left superficial femoral artery ,-168.0
Cardiohelp System with a 7.0 HLS Set Advanced Bioline Coating ,-168.0
blood flow of 3.3 l/min at 3800 rpm ,-168.0
extracorporeal blood flow (ECBF) ,-168.0
mean arterial pressure (MAP) ,-168.0
noradrenaline (80 µg/min) ,-168.0
vasopressin (2 units/h) ,-168.0
levosimendan (0.5 mg/h) ,-168.0
hydrocortisone (200 mg/d) ,-168.0
Continuous venovenous hemodiafiltration (CVVHDF) ,-168.0
anti-infective therapy ,-168.0
dose-adjustment of meropenem ,-168.0
ciprofloxacin ,-168.0
metronidazole ,-168.0
cotrimoxazole ,-168.0
liposomal amphotericin B ,-168.0
acyclovir ,-168.0
linezolid was replaced by vancomycin ,-168.0
Procalcitonin (PCT) ,-168.0
C-reactive protein (CRP) ,-168.0
MAP declined to 40 torr ,-24.0
increasing doses of vasopressors ,-24.0
LVEF further decreased below 10% ,-24.0
levosimendan infusion was stopped ,-24.0
acute ischemic injury of the non-cannulated leg ,-24.0
right femoral artery was dissected ,-24.0
insufficient blood inflow due to low cardiac output ,-24.0
lactate levels rose to 25 mmol/l ,-24.0
Dacron conduit was sewed on the right femoral artery ,-24.0
second arterial cannula (13 Fr/15 cm) ,-24.0
Y-connector ,-24.0
ECBF could be enhanced to 4–5 l/min ,-24.0
MAP could be maintained at 40–50 torr ,-24.0
venous drainage pressures could be reduced ,-24.0
sufficient preload within the right atrium and vena cava ,-24.0
echocardiography ,-24.0
inspiratory oxygen fraction of the respirator was increased ,-24.0
arterial oxygen partial pressure in blood drawn from the right radial artery was normal ,-24.0
PCT levels rose to 42.5 ng/ml ,-24.0
Hickman catheter was explanted ,-24.0
broad-complex tachycardia ,-24.0
esmolol and metoprolol ,-24.0
left ventricular function further decreased ,-24.0
aortic valve ceased to open ,-24.0
pulmonary edema ,-24.0
intracardiac clot formation ,-24.0
second venous cannula (21 Fr/55 cm) ,-24.0
percutaneous atrioseptostomy ,-24.0
left atrium ,-24.0
ECBF now reached 5–6 l/min ,-24.0
lactate levels peaked at 29 mmol/l ,-24.0
MAP rose from a nadir of 30 torr ,-24.0
cerebral oximetry by near infrared spectroscopy ,-24.0
sufficient regional oxygen saturation ,-24.0
therapeutic anticoagulation ,-24.0
unfractionated heparin ,-24.0
target partial thrombin time of 60–80 s ,-24.0
PCT peaked with 80.4 ng/ml ,-24.0
CRP peaked with 7.23 mg/dl ,-24.0
leukocytes remained low ,-24.0
high-sensitive troponin T increased ,-24.0
creatine kinase MB increased ,-24.0
all microbial specimens collected remained negative ,-24.0
viral myocarditis was excluded ,-24.0
myocardial biopsy ,-24.0
cardiac systolic function gradually recovered ,-24.0
ECMO cannulas in the left femoral vessels were removed ,-72.0
ECMO was completely removed ,-72.0
LVEF had recovered to approximately 30% ,-72.0
mean arterial pressures of 60–70 torr ,-72.0
CVVHDF could be stopped ,-72.0
renal function was normal ,-72.0
leucocyte count recovered to 1000/µl ,-72.0
normal values were reached spontaneously ,-72.0
respirator weaning was reached ,-72.0
successful allogenic stem cell transplantation ,-72.0
allogenic stem cell transplantation ,-72.0
severe critical illness ,-72.0
polyneuropathy ,-72.0
LVEF recovered to approximately 40% ,-72.0
